News

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
According to Taylor Fazio, RD, a wellness advisor at The Lanby in New York City, fiber supplements can support digestive ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Instant ramen maker Nissin Foods is leveraging the buzz around GLP-1s to launch in the US a trio of decadent tasting frozen ...
Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for ...
A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...